Dudediligence.

Novartis AG

NVSNYSE
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

1.91B

on 2025-12-31 10-Q ↗

a raise that quarter, at its price

500M1B1.5B2BDec2025

Newest

F-3ASR of 2024-09-16. Not read yet. F-3ASR ↗

2 of its filings are not read yet.

Warrants

No warrant count read from a 10-Q or 10-K.

Cash

No cash figure on file in the XBRL facts.

Raised
DateWhatSharesPriceGrossFiling
2026-03-17Public offeringnot readnot readnot read424B5 ↗
2025-11-04Public offeringnot readnot readnot read424B5 ↗